9 /100
LOW RISK
Score updated Jul 13, 2026

CVS — CVS Health Corporation Dilution Risk Tracker

Track CVS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CVS — Get alerts when the score changes →

As of July 13, 2026, CVS Health Corporation (CVS) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. CVS Health Corporation has a market capitalization of $116.08B, 1.28B shares outstanding, 1879 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CVS.
🔔 Track CVS — Get forecast alerts →

💹 Market Data

Market Cap$116.08B
Shares Outstanding1.28B
Float1.27B
Cash$11.80B
Debt$71.67B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 21.1% shares (2026Q1 vs prior)
1879 institutional holders · 1.47B shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 165.30M shares
#2 BlackRock, Inc. 125.92M shares
#3 DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 88.82M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest19.94M
Days to Cover2.3
% of Float1.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for CVS Shareholders

CVS Health Corporation (CVS) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CVS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CVS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CVS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CVS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CVS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

LBTYA LBTYK AER AIG BABA

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CVS
📊 CVS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CVS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.